Anti-MuV Drug Discovery Products

Mumps Virus (MuV), officially known as Orthorubulavirus parotitidis, is a member of Rubulavirus genus within the Paramyxoviridae family. MuV has historically caused outbreaks in populations worldwide, resulting in the characteristic symptoms of mumps. Humans are the primary hosts. This virus contains a single serotype and twelve genotypes. The MuV spreads through respiratory droplets and causes symptoms including painful swelling of the parotid glands, fever, and headache. However, sometimes, MuV infection also can lead to serious complications such as meningitis, pancreatitis, and encephalitis.

The virion is a small, enveloped virus with 120-200 nm in diameter. The genome is a single-stranded RNA with approximately 15kb in length. The genome encodes several proteins including N, P, M, F, HN, and L. The hemagglutinin-neuraminidase protein (HN) is involved in host cell attachment and release of virus progeny. The HN protein is a target for the immune response during mumps virus infection, and antibodies against this protein can neutralize the virus and contribute to immune protection. Therefore, antibodies targeting the HN protein of MuV can be used in research studies to detect the presence of the virus, investigate its interaction with host cells, and develop diagnostic assays.

Working with Creative Biolabs which specializes in virology research can ensure the quality and reliability of the antibodies. We are providing clients with anti-MuV antibodies that can be used in various virology research applications.